Evolus (EOLS) Exchange Rate Effect (2022 - 2026)
Evolus (EOLS) reported Exchange Rate Effect of -$10000.0 for Q1 2026, down 115.15% on a YoY basis from $66000.0 in Q1 2025, and up 97.7% quarter-over-quarter from -$435000.0 in Q4 2025.
Evolus (EOLS) Exchange Rate Effect (2022 - 2026) Analysis & Trends
Evolus has reported Exchange Rate Effect for 5 years, with the latest figure at -$10000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 115.15% year-over-year to -$10000.0; the trailing twelve-month figure through Mar 2026 stood at $178000.0 (up 163.12% YoY), and the FY2025 full-year result was $254000.0, up 153.14% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$10000.0, up from -$435000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $384000.0 in Q3 2025, with the low at -$435000.0 in Q4 2025.
- Historically, Exchange Rate Effect has averaged -$38882.4 across 5 years, with a median of -$62000.0 in 2022.
- Annual changes were most pronounced in 2024 — Exchange Rate Effect sank 220.67% — and 2025, when it surged 643.18%.
- Evolus' Exchange Rate Effect stood at $31000.0 in 2022, then jumped by 477.42% to $179000.0 in 2023, then slumped by 220.67% to -$216000.0 in 2024, then sank by 101.39% to -$435000.0 in 2025, then surged by 97.7% to -$10000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$10000.0 (Q1 2026), -$435000.0 (Q4 2025), and $384000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -17.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 17.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -5.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -2.38 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -22,000.00 |
| 10 | Evolus | 437.40 Mn | 387.61 Mn | 48.90 Mn | -10,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10,000.00 |
| Mar 31, 2026 | -10,000.00 |
| Dec 31, 2025 | -435,000.00 |
| Dec 31, 2025 | -435,000.00 |
| Sep 30, 2025 | 384,000.00 |
| Sep 30, 2025 | 384,000.00 |
| Jun 30, 2025 | 239,000.00 |
| Jun 30, 2025 | 239,000.00 |
| Mar 31, 2025 | 66,000.00 |
| Mar 31, 2025 | 66,000.00 |
| Dec 31, 2024 | -216,000.00 |
| Dec 31, 2024 | -216,000.00 |
| Sep 30, 2024 | -88,000.00 |
| Sep 30, 2024 | -88,000.00 |
| Jun 30, 2024 | -44,000.00 |
| Jun 30, 2024 | -44,000.00 |
| Mar 31, 2024 | -130,000.00 |
| Mar 31, 2024 | -130,000.00 |
| Dec 31, 2023 | 179,000.00 |
| Dec 31, 2023 | 179,000.00 |